USD10
SANA Shares
About Sana BiotechnologySana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
USD10
SANA Shares
About Sana BiotechnologySana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM UTC
MARKET CAP
$788.82M
OPEN PRICE
$2.76
LOW (1Y)
$2.61
HIGH (1Y)
$6.55
LOW (24H)
$2.62
HIGH (24H)
$2.76
VOLUME (24H)
$1.44M
51.81%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.76 | |
1 Day | $2.79 | |
1 Week | $2.90 | |
1 Month | $3.14 | |
1 Year | $4.35 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.